These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 352988)
21. Specificity of tumor-associated antibodies in sera of patients with uveal melanoma. Brownstein S; Phillips TM; Lewis MG Can J Ophthalmol; 1978 Jul; 13(3):190-3. PubMed ID: 698890 [TBL] [Abstract][Full Text] [Related]
23. Carcinoembryonic antigen in aqueous humor of patients with primary malignant choroidal melanoma. Zonis S; Bartal A; Navon D; Ayalon D Ann Ophthalmol; 1979 Sep; 11(9):1345-7. PubMed ID: 556157 [TBL] [Abstract][Full Text] [Related]
24. Contractile protein antigens in the cells of malignant melanoma of the choroid and their diagnostic significance. Rahi AH; Garner A; Malaty AH Br J Ophthalmol; 1978 Jun; 62(6):394-401. PubMed ID: 666989 [TBL] [Abstract][Full Text] [Related]
25. A rapid assay for stimulation of human lymphocytes by tumor-associated antigens. Roth JA; Grimm EA; Morton DL Cancer Res; 1976 Sep; 36(9 pt.1):3001-10. PubMed ID: 975069 [TBL] [Abstract][Full Text] [Related]
26. [Value of serologic tumor tests in malignant melanoma of the choroid]. Dieckhues B Klin Monbl Augenheilkd; 1986 Feb; 188(2):114-7. PubMed ID: 3713079 [TBL] [Abstract][Full Text] [Related]
27. Immunofluorescent detection of antibodies to ocular melanomas. Wong IG; Oskvig RM Arch Ophthalmol; 1974 Aug; 92(2):98-102. PubMed ID: 4136249 [No Abstract] [Full Text] [Related]
28. Studies of tumor-infiltrating lymphocytes from a human choroidal melanoma. Ksander BR; Rubsamen PE; Olsen KR; Cousins SW; Streilein JW Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3198-208. PubMed ID: 1748551 [TBL] [Abstract][Full Text] [Related]
29. Relationship of iris nevi to malignant melanoma of the uvea. Michelson JB; Shields JA Am J Ophthalmol; 1977 May; 83(5):694-6. PubMed ID: 868968 [TBL] [Abstract][Full Text] [Related]
30. [Distribution of the HLA antigen system in melanoblastoma of the uvea]. Ignatov RK; Terent'eva LS; Shul'gina NS Oftalmol Zh; 1977; 32(4):289-94. PubMed ID: 896116 [No Abstract] [Full Text] [Related]
32. Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans. Rubin JT; Elwood LJ; Rosenberg SA; Lotze MT Cancer Res; 1989 Dec; 49(24 Pt 1):7086-92. PubMed ID: 2582450 [TBL] [Abstract][Full Text] [Related]
33. Characterization of surface antigens of transplantable melanomas in hamster on the basis of the macrophage migration inhibition test. Kozłowska K; Zurawska-Czupa B; Kostulak A Arch Immunol Ther Exp (Warsz); 1981; 29(1):137-42. PubMed ID: 7283676 [TBL] [Abstract][Full Text] [Related]
35. Tumor-specific immunity in patients with malignant melanoma. Arlen M; Hollinshead A; Scherrer J Surg Forum; 1977; 28():168-9. PubMed ID: 83008 [No Abstract] [Full Text] [Related]
36. Mouse monoclonal antibody to a melanoma-carcinoma-associated antigen synthesized by a human melanoma cell line propagated in serum-free medium. Chee DO; Yonemoto RH; Leong SP; Richards GF; Smith VR; Klotz JL; Goto RM; Gascon RL; Drushella MM Cancer Res; 1982 Aug; 42(8):3142-7. PubMed ID: 7046918 [TBL] [Abstract][Full Text] [Related]
37. [Immunological studies in intraocular tumors]. Kotelianskiĭ EO Oftalmol Zh; 1982; 37(1):54-8. PubMed ID: 7043350 [No Abstract] [Full Text] [Related]
38. [Immunologic tumor diagnosis using changes in migration velocity of cells in an electrical field (cytopherometer)]. Dieckhues B; Klein J; Küchle HJ Fortschr Ophthalmol; 1984; 81(4):367-9. PubMed ID: 6479805 [No Abstract] [Full Text] [Related]